This data comes as welcome news for patients with lupus-related kidney disease.
The Foundation is currently accepting applications from lupus investigators and student researchers for our Career Development and Student Summer Fellowship grant programs.
In a victory for research advocates, on December 13, President Barack Obama signed the 21st Century Cures Act into law.
Fast Track is a process designed to expedite FDA review and get important new drugs to the patient earlier.
Over a year of advocacy efforts have paid off as the bill now moves to the President for signature.
Lupus is the feature of a new publication by the largest non-profit alliance committed to making medical research a national priority.
This week, LFA-supported researchers will share results of a study that could help expedite the delivery of new and safer therapies to people with lupus.
Aurinia Pharmaceuticals announced its plans for a single Phase III clinical trial for voclosporin in the treatment of lupus nephritis.